Canada markets closed

ContraVir Pharmaceuticals, Inc. (CTRVP)

Other OTC . Currency in USD
Add to watchlist
- (-)
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
35,640
35,640
33,269
20,395
11,997
Selling General and Administrative
9,618
9,618
10,348
10,008
8,149
Total Operating Expenses
45,258
45,258
43,618
30,403
20,146
Operating Income or Loss
-45,258
-45,258
-43,618
-30,403
-20,146
Interest Expense
9.465
9.465
10.164
8.859
31.229
Total Other Income/Expenses Net
-4,068
-4,068
-1,456
-2,310
-146.05
Income Before Tax
-49,335
-49,335
-45,084
-32,722
-20,323
Income Tax Expense
-409.022
-409.022
-2,884
0
30.584
Income from Continuing Operations
-48,926
-48,926
-42,200
-32,722
-20,354
Net Income
-48,926
-48,926
-42,200
-32,722
-20,354
Net Income available to common shareholders
-48,926
-48,926
-45,338
-32,722
-20,359